The merger of NYU Langone Health with NYU Winthrop Hospital (now NYU Langone Hospital—Long Island) in 2019 established a second Perlmutter Cancer Center campus on Long Island for patients to access care for solid tumors and blood malignancies. Since then, the Long Island center has become a hub for treatment and advanced research, including the launch of innovative clinical trials. It now provides cancer care to residents of Long Island—without the need to travel to Manhattan.
“With the merger, a large number of physicians have come into our orbit,” says John D. Allendorf, MD, professor in the Department of Surgery at NYU Long Island School of Medicine and director of network relations at Perlmutter Cancer Center on Long Island. “Those physicians are now able to refer patients to the surgeons at NYU Langone Hospital—Long Island and are available for our surgeons to refer patients out for different services.”
An ever-increasing number of practices on Long Island have come under the NYU Langone umbrella, Dr. Allendorf says.
The minimally invasive surgery program, which enables surgeons to perform procedures with smaller incisions and shorter recovery time, now uses 6 robots with 60 percent of the procedures being performed for cancer. The program has doubled the number of robots available for surgeons, alleviating a bottleneck that resulted from the increase in referrals from local providers. Read more.
